OptumRx Inc.

A just-filed Federal Trade Commission legal action against pharmacy benefit managers CVS Caremark , Express Scripts and OptumRx and their group purchasing organizations for insulin rebating pract

Alternatives to the top pharmacy benefits managers say they have fairer and more cost-effective business models for administering employers’ drug benefits, but the vertical integration and power of th

Madrigal Pharmaceuticals, Inc. reported $14.6m in second quarter US sales revenue for Rezdiffra (resmetirom) on 7 August, which the company and analysts both described as a solid early launch for the

Top executives at the three largest pharmacy benefit managers largely stuck to the script despite bipartisan skepticism and the growing frustration of the House Oversight and Accountability Committee